Capricor Therapeutics, Inc. (CAPR) vs Kamada Ltd. (KMDA)
A side-by-side comparison of Capricor Therapeutics, Inc. and Kamada Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAPR
Capricor Therapeutics, Inc.
$7.69HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
KMDA
Kamada Ltd.
$8.16HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
Total return — CAPR vs KMDA
growth of $100 · dividends reinvested · last 10yCAPR -76.9% (-13.6%/yr)KMDA +65.0% (+5.1%/yr)KMDA compounded faster over this window
Log scale — wide-divergence pair
CAPR KMDA
CAPR vs KMDA: by the numbers
- •KMDA is the larger company ($470M vs $442M market cap).
- •KMDA is profitable (11.60% net margin) while CAPR runs a net loss (0.00%).
- •KMDA pays a dividend (5.25% yield), while CAPR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CAPR | KMDA |
|---|---|---|
| P/E ratio | N/A | 21.52 |
| Forward P/E | N/A | 17.08 |
| P/S ratio | N/A | 2.45 |
| P/B ratio | 1.80 | 1.75 |
| EV / EBITDA | 0.44 | 10.50 |
| FCF yield | N/A | 5.63% |
Profitability
| Metric | CAPR | KMDA |
|---|---|---|
| Gross margin | 0.00% | 40.82% |
| Operating margin | 0.00% | 14.51% |
| Net margin | 0.00% | 11.60% |
| ROE | -52.56% | 8.25% |
| ROIC | -40.25% | 6.95% |
Dividends
| Metric | CAPR | KMDA |
|---|---|---|
| Dividend yield | N/A | 5.25% |
| Payout ratio | N/A | 110.82% |
Growth (annualized)
| Metric | CAPR | KMDA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.59% |
| EPS CAGR (5Y) | N/A | -1.98% |
| FCF CAGR (5Y) | N/A | 40.37% |
| Total return CAGR (5Y) | 15.17% | 10.36% |
Frequently asked
- Does CAPR or KMDA pay a bigger dividend?
- KMDA pays a dividend (5.25% yield), while CAPR has no payments in the available dividend history.
- Is CAPR or KMDA more profitable?
- KMDA runs the higher net margin — CAPR at 0.00% versus KMDA at 11.60%.
- How have CAPR and KMDA total returns compared?
- Over the past 10 years, CAPR delivered -13.84% and KMDA delivered 5.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Kamada P/E ratioKamada dividend yieldCapricor Therapeutics ROEKamada ROECapricor Therapeutics operating marginKamada operating marginCapricor Therapeutics revenue growthKamada revenue growthCapricor Therapeutics free cash flowKamada free cash flow
Capricor Therapeutics & Kamada appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.